To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Genoa targets nexus of biology and technology with new fund
The San Francisco firm, which raised $30m for its debut, announces it has held a final close on $84m for its sophomore vehicle.
